wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33752605-469890E6-510C-420D-8C0B-14A4CE528F4C
Q33752605-469890E6-510C-420D-8C0B-14A4CE528F4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33752605-469890E6-510C-420D-8C0B-14A4CE528F4C
Phase III data for abiraterone in an evolving landscape for castration-resistant prostate cancer.
P2860
Q33752605-469890E6-510C-420D-8C0B-14A4CE528F4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33752605-469890E6-510C-420D-8C0B-14A4CE528F4C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2ee90dcf79e55d549c8f009176a3c1dd14c77f39
P2860
Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy.